Biotech Stocks Are Back on the Map: Work on Genetics Turns Profit, Heads
Washington Post 1999 December 29; p. E1, E10
Showing items related by title, author, creator and subject.
Cracking the Code: A Bold Business Experiment Is Unfolding at Celera Genomics, Where Scientists Face a Herculean Task: Unravel the 3.5 Billion Letters of the Human Genetic Code. The Big Question for Investors: Can the Maryland Biotech Company Earn a Profit on Its Research? Gillis, Justin (1999-09-27)